NuVasive's average Accounts Receivable for the
three
months ended in Jun. 2023 was $259 Mil. NuVasive's Revenue for the
three
months ended in Jun. 2023 was $318 Mil.
Hence, NuVasive's Days Sales Outstanding for the
three
months ended in Jun. 2023 was 74.24.
The historical rank and industry rank for NuVasive's Days Sales Outstanding or its related term are showing as below:
NUVA'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 50.95 Med: 64.78 Max: 74.4
Current: 74.4
During the past 13 years, NuVasive's highest Days Sales Outstanding was 74.40. The lowest was 50.95. And the median was 64.78.
NUVA's Days Sales Outstanding is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 64.66
vs NUVA: 74.40
NuVasive's Days Sales Outstanding
increased
from Jun. 2022 (68.34) to Jun. 2023 (74.24).
NuVasive Days Sales Outstanding Historical Data
The historical data trend for NuVasive's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of NuVasive's Days Sales Outstanding
For the Medical Devices subindustry, NuVasive's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NuVasive's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, NuVasive's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where NuVasive's Days Sales Outstanding falls into.
NuVasive Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NuVasive (NAS:NUVA) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
NuVasive Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of NuVasive's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
NuVasive Inc is a medical technology company focused on developing, manufacturing, selling and providing procedural solutions for spine surgery, with a guiding purpose to transform surgery, advance care and change lives. The company has a portfolio of procedurally integrated spine surgery solutions, including surgical access instruments, spinal implants, fixation systems, biologics, and enabling technologies, as well as systems and services for intraoperative neuromonitoring. It also develop and sell magnetically adjustable implant systems for spine and specialized orthopedic procedures.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NUVA has been successfully added to your 